Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Journal of Medicinal Chemistry|November 1, 2021
Discovery of the Triazolo[1,5-<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug ResistanceShuai Wang, Sai-Qi Wang, Qiu-Xu Teng, et al.Drug Discovery Today|June 8, 2019
Revisiting mTOR inhibitors as anticancer agentsQiu-Xu Teng, Yunali V Ashar, Pranav Gupta, et al.Bioorganic Chemistry|March 26, 2023
Design, synthesis, and biological evaluation of phenylurea indole derivatives as ABCG2 inhibitorsGao-Jie Ye, Chao-Yun Cai, Xing-Duo Dong, et al.Journal of Medicinal Chemistry|October 19, 2024
Cell-Based Screen Identifies a Highly Potent and Orally Available ABCB1 Modulator for Treatment of Multidrug ResistanceShuai Wang, Sai-Qi Wang, Xiao-Bing Chen, et al.Frontiers in Pharmacology|March 30, 2022
The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 TransporterHan Fu, Zhuo-Xun Wu, Zi-Ning Lei, et al.Cancers|November 7, 2020
Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer CellsYongchao Zhang, Zhuo-Xun Wu, Yuqi Yang, et al.Acta Pharmaceutica Sinica. B|June 1, 2022
MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: <i>In vitro</i> and <i>in vivo</i> studyZhuo-Xun Wu, Qiu-Xu Teng, Yuqi Yang, et al.Frontiers in Oncology|August 22, 2022
Anticancer effect of Indanone-based thiazolyl hydrazone derivative on p53 mutant colorectal cancer cell lines: An <i>in vitro</i> and <i>in vivo</i> studySilpa Narayanan, Qiu-Xu Teng, Zhuo-Xun Wu, et al.Frontiers in Pharmacology|October 26, 2018
Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer CellsWei Zhang, Ying-Fang Fan, Chao-Yun Cai, et al.Signal Transduction and Targeted Therapy|October 8, 2022
Signaling pathways and therapeutic interventions in gastric cancerZi-Ning Lei, Qiu-Xu Teng, Qin Tian, et al.Pageof 6